Kinetic rate proteasome flowing during processing by the proteasome inhibitor (bortezomib Velcade ®) in multiple myeloma [Cinetique du taux de proteasome circulant au cours du traitement par inhibiteur du proteasome (bortezomib, Velcade) au cours du myelome multiple.]

Trial Profile

Kinetic rate proteasome flowing during processing by the proteasome inhibitor (bortezomib Velcade ®) in multiple myeloma [Cinetique du taux de proteasome circulant au cours du traitement par inhibiteur du proteasome (bortezomib, Velcade) au cours du myelome multiple.]

Recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Aug 2011

At a glance

  • Drugs Bortezomib (Primary)
  • Indications Multiple myeloma
  • Focus Pharmacodynamics
  • Most Recent Events

    • 23 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top